Literature DB >> 11285664

HIV/AIDS and blindness.

P G Kestelyn1, E T Cunningham.   

Abstract

Nearly 34 million people are currently living with HIV/AIDS: ocular complications are common, affecting 50% to 75% of all such patients at some point during the course of their illness. Cytomegalovirus retinitis is by far the most frequent cause of vision loss in patients with AIDS. Although the prevalence of cytomegalovirus retinitis is decreasing in industrialized countries because of the widespread availability of highly active antiretroviral therapy, between 10% and 20% of HIV-infected patients worldwide can be expected to lose vision in one or both eyes as a result of ocular cytomegalovirus infection. Less frequent but important causes of bilateral vision loss in patients with HIV/AIDS include varicella zoster virus and herpes simplex virus retinitis, HIV-related ischaemic microvasculopathy, ocular syphilis, ocular tuberculosis, cryptococcal meningitis, and ocular toxic or allergic drug reactions. At present, most patients with HIV/AIDS in developing countries who lose their vision have a very limited life expectancy. As antiretroviral therapy makes its way to these countries, however, both life expectancy and the prevalence of blindness related to HIV/AIDS can be expected to increase dramatically.

Entities:  

Mesh:

Year:  2001        PMID: 11285664      PMCID: PMC2566369     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  28 in total

1.  HIV/AIDS: What is the Impact on Prevention of Blindness Programmes?

Authors: 
Journal:  Community Eye Health       Date:  2003

2.  Ocular Lesions Associated with Human Immunodeficiency Virus Infection.

Authors:  A K Upadhyay; N Vichare
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  HIV- and AIDS-related Ocular Manifestations in Tanzanian Patients.

Authors:  Soumendra Sahoo
Journal:  Malays J Med Sci       Date:  2010-01

4.  Ocular findings in human immunodeficiency virus patients in Washington, DC.

Authors:  Mona A Kaleem; Shweta Ramsahai; Katrina Del Fierro; Samad Rasul; Chavon Onumah; Valerie Lerebours; Jhansi Gajjala; Robert A Copeland; Leslie S Jones
Journal:  Int Ophthalmol       Date:  2012-03-27       Impact factor: 2.031

5.  Ocular manifestation and their associated factors among HIV/AIDS patients receiving highly active antiretroviral therapy in Southern Ethiopia.

Authors:  Anteneh Amsalu; Kindie Desta; Demiss Nigussie; Demoze Delelegne
Journal:  Int J Ophthalmol       Date:  2017-05-18       Impact factor: 1.779

6.  Ocular complications of HIV infection in sub-Sahara Africa.

Authors:  Oathokwa Nkomazana; Dintle Tshitswana
Journal:  Curr HIV/AIDS Rep       Date:  2008-08       Impact factor: 5.071

7.  HIV-infected individuals on long-term antiretroviral therapy are at higher risk for ocular disease.

Authors:  E Schaftenaar; N S Khosa; G S Baarsma; C Meenken; J A McINTYRE; A D M E Osterhaus; G M G M Verjans; R P H Peters
Journal:  Epidemiol Infect       Date:  2017-05-19       Impact factor: 4.434

8.  Differing spectrum of HIV-associated ophthalmic disease among patients starting antiretroviral therapy in India and South Africa.

Authors:  Sophia Pathai; Clare Gilbert; Helen A Weiss; Matthew McNally; Stephen D Lawn
Journal:  Trop Med Int Health       Date:  2011-01-05       Impact factor: 2.622

Review 9.  Anterior segment manifestations of human immunodeficiency virus/acquired immune deficiency syndrome.

Authors:  Jyotirmay Biswas; S Sudharshan
Journal:  Indian J Ophthalmol       Date:  2008 Sep-Oct       Impact factor: 1.848

10.  Complete Binocular Blindness as the First Manifestation of HIV-Related Cryptococcal Meningitis.

Authors:  Yun-Jeong Hong; San Jung; Ji-Young Kim; Seok-Beom Kwon; Ki-Bong Song; Sung-Hee Hwang; Yang-Ki Min; Ki-Han Kwon; Byung-Chul Lee
Journal:  J Clin Neurol       Date:  2007-12-20       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.